Femasys Corp (FEMY): Utang-utang marang kapitalisasi buku

Tandha merek Femasys Inc (FEMY)

Robotic capacities in Georgia ensure a stable output of instruments, which correlates with the capital structure risk metric on the balance sheet, where the value of 1.25 characterizes this level. Femasys Inc. (FEMY) management is focused on the imminent acquisition of clearances for the implementation of minimally invasive systems. Commercial development relies on current office solutions for contraception and infertility diagnostics.

FEMY (Femasys Corporation) riwayat Utang marang nilai buku saka 04.07.2022 nganti 27.10.2026
Produk asli Femasys Corporation

For Femasys Inc., which implements AI modules and billing systems, the balance of borrowed funds is critically important when scaling software. This ratio compares total liabilities to equity on the balance sheet. By analyzing the trend of the total debt-to-equity ratio, an investor assesses the degree of financial leverage. A decrease in this indicator minimizes bankruptcy risk but limits growth rates. The current capital structure determines the company's stability during its period of technological transformation.

Karo sapa Femasys Inc. saingan

ISRG - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku danaher.com DHR|Utang-utang marang kapitalisasi buku BDX (Becton Dickinson)|STE - Utang-utang marang aset resik|WST (West Pharmaceutical Services Inc) - Utang-utang marang kapitalisasi buku|Baxter Healthcare (BAX) - Utang marang nilai buku|MASI (Masimo Corporation) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku STVN|Rasio utang marang kapitalisasi buku Teleflex (TFX)|Rasio utang marang kapitalisasi buku Merit Medical Systems, Inc. MMSI|Utang marang nilai buku Envista Holdings Corp|Rasio utang marang aset resik ICU Medical Inc. ICUI|Utang-utang marang kapitalisasi buku XRAY (DENTSPLY SIRONA Inc.)|LMAT: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku AtriCure|STAA (STAAR Surgical Co.) - Rasio utang marang nilai buku|NAGE: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik ZimVie Corp (ZIMV)|Utang marang nilai buku AngioDynamics, Inc.|Utang marang modal buku CERS (cerus.com)|Rasio utang marang kapitalisasi buku Teknova|MGRM - Rasio utang marang aset resik|Sharps Tech - Utang marang nilai buku|INFU: Utang-utang marang kapitalisasi buku|UTMD (Utah Medical Products) - Rasio utang marang kapitalisasi buku|KORU Medical (KRMD) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku NYXH (Nyxoah)|Utang-utang marang nilai buku MBOT|Rasio utang marang kapitalisasi buku Pro-Dex Corp PDEX|Rasio utang marang nilai buku Zentek Corp ZTEK|Utang marang nilai buku Elutia Inc. (ELUT)|milestonescientific.com - Utang marang modal buku|Rasio utang marang kapitalisasi buku NXGL (NEXGEL)|RVP - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku Harvard Bioscience, Inc. (HBIO)|Meihua Medical Technologies Co., Ltd. (MHUA) - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku POAI (Predictive Oncology Inc)|Utang-utang marang nilai buku CJMB|Rasio utang marang kapitalisasi buku ATRI (Atrion)|Utang marang nilai buku NeuroMetrix Inc (NURO)